{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:20:30Z","timestamp":1794658830191,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>COVID-19, caused by SARS-CoV-2, lacks effective therapeutics. Additionally, no antiviral drugs or vaccines were developed against the closely related coronavirus, SARS-CoV-1 or MERS-CoV, despite previous zoonotic outbreaks. To identify starting points for such therapeutics, we performed a large-scale screen of electrophile and non-covalent fragments through a combined mass spectrometry and X-ray approach against the SARS-CoV-2 main protease, one of two cysteine viral proteases essential for viral replication. Our crystallographic screen identified 71 hits that span the entire active site, as well as 3 hits at the dimer interface. These structures reveal routes to rapidly develop more potent inhibitors through merging of covalent and non-covalent fragment hits; one series of low-reactivity, tractable covalent fragments were progressed to discover improved binders. These combined hits offer unprecedented structural and reactivity information for on-going structure-based drug design against SARS-CoV-2 main protease.<\/jats:p>","DOI":"10.1038\/s41467-020-18709-w","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T06:02:46Z","timestamp":1602050566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":496,"title":["Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-8644","authenticated-orcid":false,"given":"Alice","family":"Douangamath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3529-7863","authenticated-orcid":false,"given":"Daren","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gehrtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-0814","authenticated-orcid":false,"given":"Tobias","family":"Krojer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Lukacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Strain-Damerell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-129X","authenticated-orcid":false,"given":"Anthony","family":"Aimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-5160","authenticated-orcid":false,"given":"P\u00e9ter","family":"\u00c1br\u00e1nyi-Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Brand\u00e3o-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Carbery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6409-8831","authenticated-orcid":false,"given":"Thomas D.","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fairhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-552X","authenticated-orcid":false,"given":"James D.","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Paul","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy M.","family":"Keser\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna F.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-9807","authenticated-orcid":false,"given":"Martin E. M.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9966-1962","authenticated-orcid":false,"given":"Peter","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-2240","authenticated-orcid":false,"given":"Ailsa","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-5349","authenticated-orcid":false,"given":"Rambabu N.","family":"Reddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-6661","authenticated-orcid":false,"given":"Rachael","family":"Skyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Snee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-8783","authenticated-orcid":false,"given":"Michael J.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2687-0699","authenticated-orcid":false,"given":"Nir","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0378-0017","authenticated-orcid":false,"given":"Frank","family":"von Delft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-1151","authenticated-orcid":false,"given":"Martin A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"18709_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265 (2020).","journal-title":"Nature"},{"key":"18709_CR2","first-page":"E79","volume":"20","author":"AJ Kucharski","year":"2020","unstructured":"Kucharski, A. J., Russell, T. W. & Diamond, C. Early dynamics of transmission and control of COVID-19: a mathematical modelling study (vol 20, pg 553, 2020). Lancet Infect. Dis. 20, E79 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"18709_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med"},{"key":"18709_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"ES Dong","year":"2020","unstructured":"Dong, E. S., Du, H. R. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533\u2013534 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"18709_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2807\/ese.17.40.20290-en","volume":"17","author":"A Bermingham","year":"2012","unstructured":"Bermingham, A. et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Eurosurveillance 17, 6\u201310 (2012).","journal-title":"Eurosurveillance"},{"key":"18709_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","volume":"362","author":"T Kuiken","year":"2003","unstructured":"Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263\u2013270 (2003).","journal-title":"Lancet"},{"key":"18709_CR7","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E. & Fouchier, R. A. M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814\u20131820 (2012).","journal-title":"N. Engl. J. Med."},{"key":"18709_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/nar\/18.7.1825","volume":"18","author":"PJ Bredenbeek","year":"1990","unstructured":"Bredenbeek, P. J. et al. The primary structure and expression of the 2nd open reading frame of the polymerase gene of the coronavirus Mhv-A59 - a Highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res. 18, 1825\u20131832 (1990).","journal-title":"Nucleic Acids Res."},{"key":"18709_CR9","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","volume":"84","author":"V Thiel","year":"2003","unstructured":"Thiel, V. et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84, 2305\u20132315 (2003).","journal-title":"J. Gen. Virol."},{"key":"18709_CR10","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1111\/febs.12936","volume":"281","author":"RFrom Hilgenfeld","year":"2014","unstructured":"Hilgenfeld, R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. Febs J. 281, 4085\u20134096 (2014).","journal-title":"Febs J."},{"key":"18709_CR11","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1016\/j.bmcl.2007.08.031","volume":"17","author":"AK Ghosh","year":"2007","unstructured":"Ghosh, A. K. et al. Structure-based design,synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors. Bioorg. Med. Chem. Lett. 17, 5876\u20135880 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"18709_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.chembiol.2008.04.011","volume":"15","author":"KHG Verschueren","year":"2008","unstructured":"Verschueren, K. H. G. et al. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chem. Biol. 15, 597\u2013606 (2008).","journal-title":"Chem. Biol."},{"key":"18709_CR13","first-page":"1742","volume":"3","author":"HT Yang","year":"2005","unstructured":"Yang, H. T. et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 3, 1742\u20131752 (2005).","journal-title":"PLoS Biol."},{"key":"18709_CR14","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1073\/pnas.1835675100","volume":"100","author":"HT Yang","year":"2003","unstructured":"Yang, H. T. et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl Acad. Sci. USA 100, 13190\u201313195 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18709_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1085658","volume":"300","author":"K Anand","year":"2003","unstructured":"Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R. & Hilgenfeld, R. Coronavirus main proteinase (3CL(pro)) structure: basis for design of anti-SARS drugs. Science 300, 1763\u20131767 (2003).","journal-title":"Science"},{"key":"18709_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","volume":"83","author":"A Hegyi","year":"2002","unstructured":"Hegyi, A. & Ziebuhr, J. Conservation of substrate specificities among coronavirus main proteases. J. Gen. Virol. 83, 595\u2013599 (2002).","journal-title":"J. Gen. Virol."},{"key":"18709_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrmicro775","volume":"1","author":"K Stadler","year":"2003","unstructured":"Stadler, K. et al. SARS\u2014Beginning to understand a new virus. Nat. Rev. Microbiol. 1, 209\u2013218 (2003).","journal-title":"Nat. Rev. Microbiol."},{"key":"18709_CR18","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1128\/JVI.02114-07","volume":"82","author":"XY Xue","year":"2008","unstructured":"Xue, X. Y. et al. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J. Virol. 82, 2515\u20132527 (2008).","journal-title":"J. Virol."},{"key":"18709_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"LL Zhang","year":"2020","unstructured":"Zhang, L. L. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science 368, 409\u2013412 (2020).","journal-title":"Science"},{"key":"18709_CR20","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","volume":"63","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. alpha-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment. J. Med. Chem. 63, 4562\u20134578 (2020).","journal-title":"J. Med. Chem."},{"key":"18709_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1087057106296688","volume":"12","author":"WE Severson","year":"2007","unstructured":"Severson, W. E. et al. Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. J. Biomol. Screen 12, 33\u201340 (2007).","journal-title":"J. Biomol. Screen"},{"key":"18709_CR22","doi-asserted-by":"publisher","first-page":"20180422","DOI":"10.1098\/rsta.2018.0422","volume":"377","author":"SE Thomas","year":"2019","unstructured":"Thomas, S. E. et al. Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping. Philos. T R Soc. A 377,\u00a020180422 (2019).","journal-title":"Philos. T R Soc. A"},{"key":"18709_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrd.2016.109","volume":"15","author":"DA Erlanson","year":"2016","unstructured":"Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W. & Jhoti, H. Twenty years on: the impact of fragments on drug discovery. Nat. Rev. Drug Discov. 15, 605\u2013619 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"18709_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S205225251402795X","volume":"2","author":"JR Helliwell","year":"2015","unstructured":"Helliwell, J. R. & Mitchell, E. P. Synchrotron radiation macromolecular crystallography: science and spin-offs. IUCrJ 2, 283\u2013291 (2015).","journal-title":"IUCrJ"},{"key":"18709_CR25","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1039\/C5SC03115J","volume":"7","author":"OB Cox","year":"2016","unstructured":"Cox, O. B. et al. A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain. Chem. Sci. 7, 2322\u20132330 (2016).","journal-title":"Chem. Sci."},{"key":"18709_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1107\/S205979831700331X","volume":"73","author":"PM Collins","year":"2017","unstructured":"Collins, P. M. et al. Gentle, fast and effective crystal soaking by acoustic dispensing. Acta Crystallogr. Sect. D.-Struct. Biol. 73, 246\u2013255 (2017).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"18709_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1107\/S2059798316020234","volume":"73","author":"T Krojer","year":"2017","unstructured":"Krojer, T. et al. The XChemExplorer graphical workflow tool for routine or large-scale protein-ligand structure determination. Acta Crystallogr. Sect. D.-Struct. Biol. 73, 267\u2013278 (2017).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"18709_CR28","doi-asserted-by":"crossref","unstructured":"Wright, N. D. et al. The low-cost, semi-automated shifter microscope stage transforms speed and robustness of manual protein crystal harvesting. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2019.12.20.875674v1 (2019).","DOI":"10.1101\/2019.12.20.875674"},{"key":"18709_CR29","doi-asserted-by":"publisher","first-page":"8951","DOI":"10.1021\/jacs.9b02822","volume":"141","author":"E Resnick","year":"2019","unstructured":"Resnick, E. et al. Rapid covalent-probe discovery by electrophile-fragment screening. J. Am. Chem. Soc. 141, 8951\u20138968 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"18709_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1742-4658.2006.05130.x","volume":"273","author":"JH Shi","year":"2006","unstructured":"Shi, J. H. & Song, J. X. The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. Febs J. 273, 1035\u20131045 (2006).","journal-title":"Febs J."},{"key":"18709_CR31","doi-asserted-by":"crossref","unstructured":"Jin, Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","DOI":"10.1038\/s41586-020-2223-y"},{"key":"18709_CR32","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/cmdc.201200404","volume":"7","author":"RH Nonoo","year":"2012","unstructured":"Nonoo, R. H., Armstrong, A. & Mann, D. J. Kinetic template-guided tethering of fragments. ChemMedChem 7, 2082\u20132086 (2012).","journal-title":"ChemMedChem"},{"key":"18709_CR33","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1021\/jm500345q","volume":"57","author":"SG Kathman","year":"2014","unstructured":"Kathman, S. G., Xu, Z. & Statsyuk, A. V. A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases. J. Med. Chem. 57, 4969\u20134974 (2014).","journal-title":"J. Med. Chem."},{"key":"18709_CR34","doi-asserted-by":"publisher","first-page":"12442","DOI":"10.1021\/jacs.5b06839","volume":"137","author":"SG Kathman","year":"2015","unstructured":"Kathman, S. G. et al. A small molecule that switches a ubiquitin ligase from a processive to a distributive enzymatic mechanism. J. Am. Chem. Soc. 137, 12442\u201312445 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"18709_CR35","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1021\/jacs.8b13193","volume":"141","author":"H Johansson","year":"2019","unstructured":"Johansson, H. et al. Fragment-based covalent ligand screening enables rapid discovery of inhibitors for the RBR E3 ubiquitin ligase HOIP. J. Am. Chem. Soc. 141, 2703\u20132712 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"18709_CR36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature18002","volume":"534","author":"KM Backus","year":"2016","unstructured":"Backus, K. M. et al. Proteome-wide covalent ligand discovery in native biological systems. Nature 534, 570\u2013574 (2016).","journal-title":"Nature"},{"key":"18709_CR37","doi-asserted-by":"crossref","unstructured":"Pearce, N. M. et al. A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density. Nat. Commun. 8, 15123 (2017).","DOI":"10.1038\/ncomms15123"},{"key":"18709_CR38","doi-asserted-by":"publisher","first-page":"14958","DOI":"10.1021\/bi0490237","volume":"43","author":"CY Chou","year":"2004","unstructured":"Chou, C. Y. et al. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochem.-Us 43, 14958\u201314970 (2004).","journal-title":"Biochem.-Us"},{"key":"18709_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/jb\/mvm246","volume":"143","author":"S Chen","year":"2008","unstructured":"Chen, S. et al. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis. J. Biochem. 143, 525\u2013536 (2008).","journal-title":"J. Biochem."},{"key":"18709_CR40","doi-asserted-by":"publisher","first-page":"22741","DOI":"10.1074\/jbc.M502556200","volume":"280","author":"WC Hsu","year":"2005","unstructured":"Hsu, W. C. et al. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J. Biol. Chem. 280, 22741\u201322748 (2005).","journal-title":"J. Biol. Chem."},{"key":"18709_CR41","doi-asserted-by":"publisher","first-page":"14908","DOI":"10.1021\/bi0616302","volume":"45","author":"J Barrila","year":"2006","unstructured":"Barrila, J., Bacha, U. & Freire, E. Long-range cooperative interactions modulate dimerization in SARS 3CL(pro). Biochemistry 45, 14908\u201314916 (2006).","journal-title":"Biochemistry"},{"key":"18709_CR42","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2009.03.034","volume":"388","author":"TC Hu","year":"2009","unstructured":"Hu, T. C. et al. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology 388, 324\u2013334 (2009).","journal-title":"Virology"},{"key":"18709_CR43","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1021\/acs.jmedchem.9b01545","volume":"62","author":"B Kuhn","year":"2019","unstructured":"Kuhn, B., Gilberg, E., Taylor, R., Cole, J. & Korb, O. How significant are unusual protein-ligand interactions? Insights from database mining. J. Med. Chem. 62, 10441\u201310455 (2019).","journal-title":"J. Med. Chem."},{"key":"18709_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1107\/S2052252515021259","volume":"3","author":"JD Bauman","year":"2016","unstructured":"Bauman, J. D., Harrison, J. J. E. K. & Arnold, E. Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. Iucrj 3, 51\u201360 (2016).","journal-title":"Iucrj"},{"key":"18709_CR45","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1021\/acs.jmedchem.9b00304","volume":"62","author":"DJ Wood","year":"2019","unstructured":"Wood, D. J. et al. FragLites-minimal, halogenated fragments displaying pharmacophore doublets. an efficient approach to druggability assessment and hit generation. J. Med. Chem. 62, 3741\u20133752 (2019).","journal-title":"J. Med. Chem."},{"key":"18709_CR46","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1021\/jacs.8b11027","volume":"141","author":"E Mons","year":"2019","unstructured":"Mons, E. et al. The alkyne moiety as a latent electrophile in irreversible covalent small molecule inhibitors of cathepsin K. J. Am. Chem. Soc. 141, 3507\u20133514 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"18709_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1039\/C8MD00327K","volume":"10","author":"A Keeley","year":"2019","unstructured":"Keeley, A., Abranyi-Balogh, P. & Keseru, G. M. Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors. Medchemcomm 10, 263\u2013267 (2019).","journal-title":"Medchemcomm"},{"key":"18709_CR48","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.drudis.2019.03.009","volume":"24","author":"M O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly, M. et al. Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design. Drug Discov. Today 24, 1081\u20131086 (2019).","journal-title":"Drug Discov. Today"},{"key":"18709_CR49","doi-asserted-by":"publisher","first-page":"e1800184","DOI":"10.1002\/ardp.201800184","volume":"351","author":"A Keeley","year":"2018","unstructured":"Keeley, A. et al. Heterocyclic electrophiles as new MurA inhibitors. Arch. Pharm.351, e1800184 (2018).","journal-title":"Arch. Pharm."},{"key":"18709_CR50","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.drudis.2016.04.023","volume":"21","author":"N Fuller","year":"2016","unstructured":"Fuller, N. et al. An improved model for fragment-based lead generation at AstraZeneca. Drug Discov. Today 21, 1272\u20131283 (2016).","journal-title":"Drug Discov. Today"},{"key":"18709_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nchembio.1867","volume":"11","author":"CH Arrowsmith","year":"2015","unstructured":"Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11, 536\u2013541 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"18709_CR52","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1093\/bioinformatics\/btaa104","volume":"36","author":"MP Ferla","year":"2020","unstructured":"Ferla, M. P., Pagnamenta, A. T., Damerell, D., Taylor, J. C. & Marsden, B. D. MichelaNglo: sculpting protein views on web pages without coding. Bioinformatics 36, 3268\u20133270 (2020).","journal-title":"Bioinformatics"},{"key":"18709_CR53","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10545-011-9334-4","volume":"34","author":"WH Lee","year":"2011","unstructured":"Lee, W. H. et al. Interactive JIMD articles using the iSee concept: turning a new page on structural biology data. J. Inherit. Metab. Dis. 34, 565\u2013567 (2011).","journal-title":"J. Inherit. Metab. Dis."},{"key":"18709_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1107\/S2059798317003412","volume":"73","author":"NM Pearce","year":"2017","unstructured":"Pearce, N. M., Krojer, T. & von Delft, F. Proper modelling of ligand binding requires an ensemble of bound and unbound states. Acta Crystallogr. D. Struct. Biol. 73, 256\u2013266 (2017).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"18709_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd3410","volume":"10","author":"J Singh","year":"2011","unstructured":"Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. The resurgence of covalent drugs. Nat. Rev. Drug Discov. 10, 307\u2013317 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"18709_CR56","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","volume":"20","author":"RA Bauer","year":"2015","unstructured":"Bauer, R. A. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies. Drug Discov. Today 20, 1061\u20131073 (2015).","journal-title":"Drug Discov. Today"},{"key":"18709_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejmech.2017.06.019","volume":"138","author":"S De Cesco","year":"2017","unstructured":"De Cesco, S., Kurian, J., Dufresne, C., Mittermaier, A. K. & Moitessier, N. Covalent inhibitors design and discovery. Eur. J. Med. Chem. 138, 96\u2013114 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"18709_CR58","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.chembiol.2019.09.012","volume":"26","author":"T Zhang","year":"2019","unstructured":"Zhang, T., Hatcher, J. M., Teng, M., Gray, N. S. & Kostic, M. Recent advances in selective and irreversible covalent ligand development and validation. Cell Chem. Biol. 26, 1486\u20131500 (2019).","journal-title":"Cell Chem. Biol."},{"key":"18709_CR59","doi-asserted-by":"publisher","first-page":"13408","DOI":"10.1002\/anie.201601091","volume":"55","author":"TA Baillie","year":"2016","unstructured":"Baillie, T. A. Targeted covalent inhibitors for drug design. Angew. Chem. Int Ed. Engl. 55, 13408\u201313421 (2016).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"18709_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.compbiolchem.2004.11.003","volume":"29","author":"S Sirois","year":"2005","unstructured":"Sirois, S., Hatzakis, G., Wei, D., Du, Q. & Chou, K. C. Assessment of chemical libraries for their druggability. Comput. Biol. Chem. 29, 55\u201367 (2005).","journal-title":"Comput. Biol. Chem."},{"key":"18709_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/acschembio.7b00903","volume":"13","author":"JB Baell","year":"2018","unstructured":"Baell, J. B. & Nissink, J. W. M. Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations. ACS Chem. Biol. 13, 36\u201344 (2018).","journal-title":"ACS Chem. Biol."},{"key":"18709_CR62","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell, J. B. & Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53, 2719\u20132740 (2010).","journal-title":"J. Med. Chem."},{"key":"18709_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1107\/S2059798317017235","volume":"74","author":"G Winter","year":"2018","unstructured":"Winter, G. et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. Sect. D.-Struct. Biol. 74, 85\u201397 (2018).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"18709_CR64","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1107\/S0907444913015308","volume":"69","author":"G Winter","year":"2013","unstructured":"Winter, G., Lobley, C. M. C. & Prince, S. M. Decision making in xia2. Acta Crystallogr. D. 69, 1260\u20131273 (2013).","journal-title":"Acta Crystallogr. D."},{"key":"18709_CR65","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D."},{"key":"18709_CR66","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D."},{"key":"18709_CR67","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. Sect. D.-Struct. Biol. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"18709_CR68","unstructured":"Buster v. 2.10.13 (Cambridge, United Kingdom, 2017)."},{"key":"18709_CR69","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1002\/chem.202001123","volume":"26","author":"TD Downes","year":"2020","unstructured":"Downes, T. D. et al. Design and synthesis of 56 shape-diverse 3D fragments. Chemistry 26, 8969\u20138975 (2020).","journal-title":"Chemistry"},{"key":"18709_CR70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1107\/S2059798319003528","volume":"75","author":"G Winter","year":"2019","unstructured":"Winter, G. et al. How best to use photons. Acta Crystallogr. D. Struct. Biol. 75, 242\u2013261 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"18709_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ymeth.2011.06.010","volume":"55","author":"G Winter","year":"2011","unstructured":"Winter, G. & McAuley, K. E. Automated data collection for macromolecular crystallography. Methods 55, 81\u201393 (2011).","journal-title":"Methods"},{"key":"18709_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1107\/S0907444909047374","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D. 66, 133\u2013144 (2010).","journal-title":"Acta Crystallogr. D."},{"key":"18709_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. Sect. D.-Struct. Biol. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"18709_CR74","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1107\/S2053273315099702","volume":"71","author":"R Keegan","year":"2015","unstructured":"Keegan, R., Wojdyr, M., Winter, G. & Ashton, A. DIMPLE: a difference map pipeline for the rapid screening of crystals on the beamline. Acta Crystallogr. A 71, S18\u2013S18 (2015).","journal-title":"Acta Crystallogr. A"},{"key":"18709_CR75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S2059798317000067","volume":"73","author":"F Long","year":"2017","unstructured":"Long, F. et al. AceDRG: a stereochemical description generator for ligands. Acta Crystallogr. Sect. D.-Struct. Biol. 73, 112\u2013122 (2017).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"18709_CR76","unstructured":"grade v. 1.2.19 (Global Phasing Ltd., Cambridge, United Kingdom, 2010)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18709-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18709-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18709-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:33:56Z","timestamp":1670272436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18709-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18709"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18709-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.27.118117","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5047"}}